Significant Ownership of Knight Therapeutics Inc

Signature - Title: /s/ Samira Sakhia - Samira Sakhia / President and Chief Executive Officer
Location: Montreal, Quebec, Canada
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Knight Therapeutics Inc.

Notify me when Knight Therapeutics Inc files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SNYR	Synergy CHC Corp.	Common Stock, par value $0.00001 per share	20%	$3,536,116	+$792,854	1,911,414	+29%	KNIGHT THERAPEUTICS INC.	11 Jun 2025

Schedules 13D/G Reported by Knight Therapeutics Inc:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.